D. Bottiger et al., INHIBITION OF SIV AND HIV-2 REPLICATION IN CYNOMOLGUS MONKEYS BY (-)9-[4-HYDROXY-2-(HYDROXYMETHYL)BUTYL]GUANINE (H2G), Antiviral chemistry & chemotherapy, 7(1), 1996, pp. 21-26
The antiherpes compound (-)9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine
(H2G) has been found to suppress the multiplication of SIVsm and HIV-
2 in cynomolgus monkeys. This was seen as a delay in the appearance of
viral antigen in serum during the primary infection at drug concentra
tions of 3x10 mg kg(-1) day(-1) and higher, when H2G was given subcuta
neously. These effects of H2G on SIVsm and HIV-2 replication in monkey
s were similar to those observed using the same dose of 3'-azidothymid
ine (AZT). A complete prevention of HIV-2 infection was observed in on
e of four animals treated with 3x10 mg kg(-1) day(-1) of H2G. The enan
tiomeric mixture (+/-)H2G at 3x25 mg kg(-1) day(-1) also delayed the a
ppearance of SIVsm antigen but the (+)enantiomer of H2G at 3x10 mg kg(
-1) day(-1) had no effect on primary SIVsm infection in monkeys, indic
ating that only the (-)enantiomer (H2G) was inhibitory and that this e
ffect was not influenced by the presence of the (+)enantiomer. No adve
rse effects on blood chemistry or haematology were observed in monkeys
given 25 mg kg(-1) day(-1) of H2G for 9 weeks or 3x25 mg kg(-1) day(-
1) for 10 days.